[New therapeutic strategies for remyelination in multiple sclerosis].

about

[New therapeutic strategies for remyelination in multiple sclerosis].

Item

http://www.wikidata.org/entity/Q53448928

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

[New therapeutic strategies for remyelination in multiple sclerosis].

@en

[New therapeutic strategies for remyelination in multiple sclerosis].

@nl

type

Item

label

[New therapeutic strategies for remyelination in multiple sclerosis].

@en

[New therapeutic strategies for remyelination in multiple sclerosis].

@nl

prefLabel

[New therapeutic strategies for remyelination in multiple sclerosis].

@en

[New therapeutic strategies for remyelination in multiple sclerosis].

@nl

P1476

[New therapeutic strategies for remyelination in multiple sclerosis].

@en

P2093

D Kremer

http://www.w3.org/2001/XMLSchema#string

H-P Hartung

http://www.w3.org/2001/XMLSchema#string

M Stangel

http://www.w3.org/2001/XMLSchema#string

P Küry

http://www.w3.org/2001/XMLSchema#string

P2860

From fly wings to targeted cancer therapies: a centennial for notch signaling

Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells

Profilin is an effector for Daam1 in non-canonical Wnt signaling and is required for vertebrate gastrulation

Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development

LINGO-1 negatively regulates myelination by oligodendrocytes

F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation

Retinoid X receptor gamma signaling accelerates CNS remyelination.

Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus.

Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

P2888

s00115-014-4249-6

P304

934-946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-014-4249-6

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26122637

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis